Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Effective Interest Rate on Debt % : 7.62% (As of Apr. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Proteome Therapeutics Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Advanced Proteome Therapeutics's annualized positive value of Interest Expense for the quarter that ended in Apr. 2023 was $0.02 Mil. Advanced Proteome Therapeutics's average total debt for the quarter that ended in Apr. 2023 was $0.21 Mil. Therefore, Advanced Proteome Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Apr. 2023 was 7.62%.

Advanced Proteome Therapeutics Effective Interest Rate on Debt % Historical Data

The historical data trend for Advanced Proteome Therapeutics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Effective Interest Rate on Debt % Chart

Advanced Proteome Therapeutics Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

81.40

18.62

12.22

8.68

8.84

Advanced Proteome Therapeutics Quarterly Data
	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															5.50	5.93	15.95	13.52	7.62

Competitive Comparison of Advanced Proteome Therapeutics's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Advanced Proteome Therapeutics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Proteome Therapeutics's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's Effective Interest Rate on Debt % falls into.

Advanced Proteome Therapeutics Effective Interest Rate on Debt % Calculation

Advanced Proteome Therapeutics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Jul. 2022 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Jul. 2021 )	+	Total Debt (A: Jul. 2022 ))	/ count )
=	-1 * -0.029	/	( (0.325	+	0.331)	/ 2 )
=	-1 * -0.029	/	0.328
=	8.84 %

where

	Total Debt (A: Jul. 2021 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.172	+	0.153
=	0.325

	Total Debt (A: Jul. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.227	+	0.104
=	0.331

Advanced Proteome Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Apr. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Jan. 2023 )	+	Total Debt (Q: Apr. 2023 ))	/ count )
=	-1 * -0.016	/	( (0.389	+	0.031)	/ 2 )
=	-1 * -0.016	/	0.21
=	7.62 %

where

	Total Debt (Q: Jan. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.237	+	0.152
=	0.389

	Total Debt (Q: Apr. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0.031
=	0.031

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Apr. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Advanced Proteome Therapeutics (OTCPK:APTCF) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Advanced Proteome Therapeutics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

0E81:Germany APC.H:Canada

Address

8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2

Website

https://www.advancedproteome.com

Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Headlines

From GuruFocus

Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement

By GlobeNewswire GlobeNewswire • 08-23-2018

Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director

By GlobeNewswire GlobeNewswire • 06-06-2018